VALNEVA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.434 EUR | +1.60% |
|
-0.29% | -27.25% |
| 04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
| 03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALNEVA | Other Biotechnology & Medical Research | +1.60% | -0.29% | -27.25% | -18.41% | +0.26% | 513M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VLA Stock
- Charts Valneva
- Comparison Chart
